Literature DB >> 4728676

Antigen-induced inhibition of experimental allergic encephalomyelitis. II. Studies in guinea pigs with the small rat myelin basic protein.

R H Swanborg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4728676

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  7 in total

1.  IFN-β Facilitates Neuroantigen-Dependent Induction of CD25+ FOXP3+ Regulatory T Cells That Suppress Experimental Autoimmune Encephalomyelitis.

Authors:  Duncheng Wang; Debjani Ghosh; S M Touhidul Islam; Cody D Moorman; Ashton E Thomason; Daniel S Wilkinson; Mark D Mannie
Journal:  J Immunol       Date:  2016-09-12       Impact factor: 5.422

2.  Suppressor T cells prevent experimental autoimmune encephalomyelitis in mice.

Authors:  C C Bernard
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

Review 3.  Coexistence of immunogenic and suppressogenic epitopes in tumor cells and various types of macromolecules.

Authors:  D Naor
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

4.  Failure of basic protein therapy for multiple sclerosis.

Authors:  R E Gonsette; P Delmotte; L Demonty
Journal:  J Neurol       Date:  1977-08-18       Impact factor: 4.849

5.  Failure of myelin basic protein to prevent or suppress experimental allergic encephalomyelitis in guinea pigs.

Authors:  G A Hashim
Journal:  Neurochem Res       Date:  1980-02       Impact factor: 3.996

Review 6.  Peptide determinants of myelin proteolipid protein (PLP) in autoimmune demyelinating disease: a review.

Authors:  V K Tuohy
Journal:  Neurochem Res       Date:  1994-08       Impact factor: 3.996

7.  Peptide-specific prevention of experimental allergic encephalomyelitis. Neonatal tolerance induced to the dominant T cell determinant of myelin basic protein.

Authors:  J P Clayton; G M Gammon; D G Ando; D H Kono; L Hood; E E Sercarz
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.